2202:HKEXChemtros Co., Ltd. Analysis
Data as of 2026-08-20 - not real-time
HK$2.44
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
China Vanke Co., Ltd. is priced at HKD 2.44, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have gained 8.0%. With RSI at 49.8 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at HKD 2.35 and resistance at HKD 2.59.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 14.2% above the current price. Revenue is contracting at 23.9% on a -39.3% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 35.3%, a beta of -0.11 and a maximum drawdown of 63.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 14.2% above the current price. Revenue is contracting at 23.9% on a -39.3% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 35.3%, a beta of -0.11 and a maximum drawdown of 63.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 3.19
- MACD momentum is negative
- 30-day price change of +8.0%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 3.19
- Analyst targets imply +14.2% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -39.3%
- Analyst targets imply +14.2% versus the current price
- Negative return on equity of -32.8%
Key Metrics & Analysis
Financial Health
Revenue Growth-23.90%
Profit Margin-39.34%
P/E Ratio-1.3
ROE-32.79%
ROA-1.22%
Debt/Equity164.21
P/B Ratio0.2
Op. Cash FlowHK$2.6B
Free Cash FlowHK$39.8B
Industry P/E32.7
Technical Analysis
TrendNeutral
RSI49.8
SupportHK$2.35
ResistanceHK$2.59
MA 20HK$2.45
MA 50HK$2.41
MA 200HK$3.19
MACDBearish
VolumeIncreasing
Fear & Greed Index92.84
Valuation
Fair ValueHK$16.14
Target PriceHK$2.79
Upside/Downside14.24%
GradeFair
TypeBlend
Risk Assessment
Beta-0.11
Volatility35.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.